CDMOs announced expansions, exhibitors showcased automated equipment, and supply chain strategy discussions were a focus at CPHI Milan 2026.
|Articles|December 2, 2013
- Pharmaceutical Technology-12-02-2013
- Volume 37
- Issue 12
Tablet Tooling Coating Reduces Formulation Sticking
Author(s)Melanie Sena
Tablet Tooling Coating Reduces Formulation Sticking
PharmaCote CX and CX+, an enhanced Chromium Nitride, are a range of coatings developed to improve the performance of substrate material for punches and dies. The coating offers a smooth finish and anti-stick performance, the company reports. PharmaCote CX provides prolonged tooling life due to a multi-layered application. It also offers up to 13 times more corrosion resistance than PharmaCote HC (Hard Chromium) and up to two times the life of PharmaCote CN (Chromium Nitride).
Articles in this issue
almost 13 years ago
Rail-Mounted Fluid Bed Dryers Allow Cleaning Accessalmost 13 years ago
Biotechnology Innovation and Growth in Israelalmost 13 years ago
Drug Manufacturing Focus: Why India?almost 13 years ago
Clinical Trials Head East to Asiaalmost 13 years ago
Climate Change in Outsourcingalmost 13 years ago
Deficiencies Found in API Inspectionsalmost 13 years ago
Q&A with Brian Galliher, Cook Pharmicaalmost 13 years ago
Inspiring the Next Generationalmost 13 years ago
Establishing a Minimum Incubation Time for Biological IndicatorsRelated to this article
Mitigating nitrosamine risk requires assessing each product individually and chasing zero nitrite in pharmaceutical excipients is often impractical and costly.
Clinical, manufacturing, safety, and commercial teams all lean on shared data. They need to agree on who publishes each data product, who can use it, and what evidence goes with it.
Continuous overall equipment effectiveness can be used to pinpoint hidden downtime and process bottlenecks in real time.
The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Bill Williams, AAPS, compares KinetiSol and spray drying for amorphous solid dispersions, covering 75% drug loading, pill burden, weakly basic drug release, and process limits.
Shubhajit Paul, a senior research fellow in Boehringer Ingelheim’s Department of Material Analytical Sciences, spoke with PharmTech at AAPS PharmSci 360 to explain how tabletability prediction can be improved for roller-compacted formulations.
Trending on Pharmaceutical Technology
1
FDA’s New Inspection Playbook Counts Remote Assessments and MRA Reports Toward Facility Evaluations
2
Improving Oral Peptide Delivery Through Structural Modifications
3
Late-Phase Impurities Need Reference Standards: AAPS PharmSci 360 2026
4
Who Answers for Your Data? Building a Life Sciences Data Mesh
5